JMP Securities raised the price target on Karuna Therapeutics Inc (NASDAQ: KRTX) from $175 to $190 with a Market Outperform rating. The analysts note Karuna as the top pick ahead of imminent Phase 3 ...
In a report published Wednesday, JMP Securities analyst Jason N. Butler initiated coverage of Axovant Sciences Ltd AXON with a Market Outperform rating and a price target of $36. Axovant is a ...
Investing.com - Citizens JMP has reiterated its Market Outperform rating and $38.00 price target on Acadia Pharmaceuticals (NASDAQ:ACAD), currently trading at $24.76, as the company prepares to report ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback